PHUPEA (Pôle Hospitalo-Universitaire de Psychiatrie de l'Enfant et de l'Adolescent), CHGR, Université de Rennes 1, 154 rue de Châtillon, Rennes 35000, France.
Hospital-University Department of Child and Adolescent Psychiatry, CHGR and University of Rennes 1, Rennes, France.
J Clin Psychiatry. 2018 Mar/Apr;79(2). doi: 10.4088/JCP.16m10889.
Autism and certain associated behaviors including self-injurious behaviors (SIB) and atypical pain reactivity have been hypothesized to result from excessive opioid activity. The objective of this study was to examine the relationships between SIB, pain reactivity, and β-endorphin levels in autism.
Study participants were recruited between 2007 and 2012 from day care centers and included 74 children and adolescents diagnosed with autism (according to DSM-IV-TR, ICD-10, and CFTMEA) and intellectual disability. Behavioral pain reactivity and SIB were assessed in 3 observational situations (parents at home, 2 caregivers at day care center, a nurse and child psychiatrist during blood drawing) using validated quantitative and qualitative scales. Plasma β-endorphin concentrations were measured in 57 participants using 2 different immunoassay methods.
A high proportion of individuals with autism displayed SIB (50.0% and 70.3% according to parental and caregiver observation, respectively). The most frequent types of SIB were head banging and hand biting. An absence or decrease of overall behavioral pain reactivity was observed in 68.6% and 34.2% of individuals with autism according to parental and caregiver observation, respectively. Those individuals with hyporeactivity to daily life accidental painful stimuli displayed higher rates of self-biting (P < .01, parental evaluation). No significant correlations were observed between β-endorphin level and SIB or pain reactivity assessed in any of the 3 observational situations.
The absence of any observed relationships between β-endorphin level and SIB or pain reactivity and the conflicting results of prior opioid studies in autism tend to undermine support for the opioid theory of autism. New perspectives are discussed regarding the relationships found in this study between SIB and hyporeactivity to pain.
自闭症和某些相关行为,包括自伤行为(SIB)和非典型疼痛反应,被认为是由于阿片类物质活性过度所致。本研究的目的是探讨自闭症中 SIB、疼痛反应和β-内啡肽水平之间的关系。
研究参与者于 2007 年至 2012 年期间从日托中心招募,包括 74 名被诊断为自闭症(根据 DSM-IV-TR、ICD-10 和 CFTMEA)和智力残疾的儿童和青少年。使用经过验证的定量和定性量表,在 3 种观察情况下评估行为性疼痛反应和 SIB(父母在家、2 名日托中心的照顾者、护士和儿童精神科医生在采血时)。使用 2 种不同的免疫测定法测量 57 名参与者的血浆β-内啡肽浓度。
自闭症患者中 SIB 的比例较高(分别根据父母和照顾者观察为 50.0%和 70.3%)。最常见的 SIB 类型为头部撞击和手部咬伤。根据父母和照顾者观察,自闭症患者的整体行为性疼痛反应缺失或减少分别为 68.6%和 34.2%。那些对日常生活意外疼痛刺激反应低下的个体,自我咬伤的发生率更高(P<0.01,父母评估)。在任何 3 种观察情况下,均未观察到β-内啡肽水平与 SIB 或疼痛反应之间存在任何显著相关性。
β-内啡肽水平与 SIB 或疼痛反应之间没有观察到任何关系,以及自闭症中阿片类物质研究的先前结果存在冲突,这往往削弱了自闭症阿片类物质理论的支持。本文讨论了 SIB 和对疼痛反应低下之间发现的关系的新视角。